These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6548524)
1. TL-350, an ergoline derivative with dopamine receptor agonist properties. Ilhan M; Long JP; Bhatnagar R; Flynn J; Cannon JG; Lee T J Pharmacol Exp Ther; 1984 Oct; 231(1):56-60. PubMed ID: 6548524 [TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor stimulating and alpha adrenoceptor blocking actions of trans (CS-265) and cis (CS-263) isomers of nonhydroxylated N-propyl octahydrobenzo[F]quinoline. Ilhan M; Long JP; Cannon JG J Pharmacol Exp Ther; 1984 Nov; 231(2):361-6. PubMed ID: 6149308 [TBL] [Abstract][Full Text] [Related]
3. Dopaminergic activity of a nonhydroxylated aminotetralin derivative (TL-68) on cat hearts. Ilhan M; Long JP; Cannon JG Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):213-9. PubMed ID: 6508433 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of dopaminergic and alpha adrenergic activities of TL-99 in peripheral tissues in vitro. Ilhan M; Long JP; Abou Zeit-Har MS; Cannon JG Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):17-28. PubMed ID: 3008675 [TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro dopaminergic effects of three ergoline fragments. Koons JC; Long JP; Cannon JG Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):180-5. PubMed ID: 6527705 [TBL] [Abstract][Full Text] [Related]
6. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis). Hopkins BJ; Hodgson WC; Sutherland SK Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats. Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926 [TBL] [Abstract][Full Text] [Related]
8. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine. Lokhandwala MF; Steenberg ML J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099 [TBL] [Abstract][Full Text] [Related]
9. Subsensitivity of the presynaptic dopamine receptors in cat heart after the termination of chronic haloperidol treatment. Verimer T; Long JP; Flynn JR; Arnerić SP; Walsh BJ Arch Int Pharmacodyn Ther; 1981 Oct; 253(2):233-40. PubMed ID: 7198898 [TBL] [Abstract][Full Text] [Related]
10. Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo. Martin GE; Williams M; Pettibone DJ; Zrada MM; Lotti VJ; Taylor DA; Jones JH J Pharmacol Exp Ther; 1985 May; 233(2):395-401. PubMed ID: 2987478 [TBL] [Abstract][Full Text] [Related]
11. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971. Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613 [TBL] [Abstract][Full Text] [Related]
12. Blood pressure and heart rate response to apomorphine in urethane anesthetized rats. Ramírez AJ; Enero MA Acta Physiol Lat Am; 1980; 30(3):199-203. PubMed ID: 7347101 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the cardiovascular effects of co-derocrine (Hydergine). Clark BJ; Bucher T; Waite R J Pharmacol; 1985; 16 Suppl 3():101-11. PubMed ID: 2869189 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic structure-activity relationships of 2-aminoindans and cardiovascular action and dopaminergic activity of 4-hydroxy, 5-methyl, 2-di-n-propylaminoindan (RD-211). Ma SX; Long JP; Flynn JR; Leonard PA; Cannon JG J Pharmacol Exp Ther; 1991 Feb; 256(2):751-6. PubMed ID: 1671601 [TBL] [Abstract][Full Text] [Related]
15. The reversal by metoclopramide of apomorphine-induced inhibition of responses to stimulation of the cardioaccelerator nerves in the cat. Tuncer M Indian J Physiol Pharmacol; 1984; 28(1):15-20. PubMed ID: 6490125 [TBL] [Abstract][Full Text] [Related]
16. Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057). Salvati P; Bianchi G Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):291-304. PubMed ID: 4026460 [TBL] [Abstract][Full Text] [Related]
17. [Experimental study of the hypotensive effect of apomorphine]. Montastruc JL; Guiol C Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1176-80. PubMed ID: 6441536 [TBL] [Abstract][Full Text] [Related]
18. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum. Capasso A; Sorrentino L Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841. Krisch I; Bole-Vunduk B; Pepelnak M; Lavric B; Ocvirk A; Budihna MV; Sket D J Pharmacol Exp Ther; 1994 Oct; 271(1):343-52. PubMed ID: 7965734 [TBL] [Abstract][Full Text] [Related]
20. Centrally mediated hypotension and bradycardia induced by an aminotetralin derivative: TL-68. Sharabi FM; Long JP; Rusterholz DB; Hoffman WE; Lee T; Cannon GJ Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):457-73. PubMed ID: 674826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]